Tci Wealth Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History

Tci Wealth Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$133.98 - $160.47 $7,904 - $9,467	-59 Reduced 62.11%	36 $5,000
Q4 2022 Feb 06, 2023	BUY	$129.72 - $159.85 $7,653 - $9,431	59 Added 163.89%	95 $15,000
Q3 2022 Nov 08, 2022	SELL	$126.59 - $161.18 $126 - $161	-1 Reduced 2.7%	36 $5,000
Q3 2021 Oct 29, 2021	SELL	$128.64 - $184.79 $4,116 - $5,913	-32 Reduced 46.38%	37 $5,000
Q2 2021 Aug 02, 2021	BUY	$160.2 - $186.42 $4,165 - $4,846	26 Added 60.47%	69 $12,000
Q2 2020 Jul 20, 2020	BUY	$95.68 - $121.88 $1,148 - $1,462	12 Added 38.71%	43 $5,000
Q1 2020 Apr 14, 2020	BUY	$87.74 - $152.74 $2,719 - $4,734	31 New	31 $3,000
Q4 2018 Jan 17, 2019	SELL	$115.94 - $166.74 $347 - $500	-3 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$161.01 - $180.57 $1,127 - $1,263	-7 Reduced 70.0%	3 $1,000
Q2 2018 Jul 27, 2018	BUY	$146.33 - $183.18 $1,463 - $1,831	10 New	10 $2,000
Q3 2017 Oct 24, 2017	SELL	$142.62 - $155.6 $7,131 - $7,780	-50 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	50	50 $8,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.